Gilder Gagnon Howe & CO LLC Karuna Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $42,667 - $84,230	-265 Reduced 3.35%	7,657 $2.42 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $4,939 - $6,542	30 Added 0.38%	7,922 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $97,328 - $132,601	552 Added 7.52%	7,892 $1.71 Million
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $37,267 - $47,207	-231 Reduced 3.05%	7,340 $1.33 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $11,108 - $13,735	-58 Reduced 0.76%	7,571 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $944,393 - $2.12 Million	7,629 New	7,629 $1.72 Million
Q1 2020 May 15, 2020	SELL	$60.41 - $115.92 $543,810 - $1.04 Million	-9,002 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $102,982 - $1.12 Million	9,002 New	9,002 $678,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.